ARCHIVES

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

ASCO Members Pick Schilsky as President-Elect; Five Elected to Society’s Board of Directors.

February 16, 2007

In Brief: OMB tells NCI Mislead Congress, Refuses Higher Budget; Ford Says He Support Program

March 28, 1975

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

Funding Opportunities

March 7, 2003